Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | DN1508052 |
Synonyms | |
Therapy Description |
DN1508052 acts as an agonist of TLR8, potentially resulting in activation of NFkappaB signaling and increased anti-tumor immune response (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
DN1508052 | DN 1508052|DN1508052-01|DN A1|DN-A1|DN-1508052 | TLR8 Agonist 9 | DN1508052 acts as an agonist of TLR8, potentially resulting in activation of NFkappaB signaling and increased anti-tumor immune response (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT03934359 | Phase I | DN1508052 | A Study to Evaluate the Safety, Tolerability of DN1508052-01 in Advanced Solid Tumors | Completed | USA | 0 |